SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $840K invested in Salarius Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$69K
2
+$11.1K

Top Sellers

1
-$119K
2
-$46.2K
3
-$32.3K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$32K
5
UBS Group
UBS Group
Switzerland
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$298K
2
$222K
3
$150K
4
$69K
5
$43K
6
$32K
7
$7K
8
$6K
9
$5K
10
$4K
11
$3K
12
$1K
13
–
14
–